Elevated levels of this genus in the gut have been shown to co-localize with cancer-associated fibroblasts (α-SMA+) and activate the TLR2/NF-κB signaling pathways, contributing to the reduction of CD8+ T cells in the colorectal cancer microenvironment [51]. This evidence concerns the gene NFKB1 and cancer.